Baylis, Sally A. ; Hanschmann, Kay-Martin O. ; Matsubayashi, Keiji ; Sakata, Hidekatsu ; Roque-Afonso, Anne-Marie ; Kaiser, Marco ; Corman, Victor M. ; Kamili, Saleem ; Aggarwal, Rakesh ; Trehanpati, Nirupma ; Gärtner, Thomas ; Thomson, Emma C. ; Davis, Christopher A. ; da Silva Filipe, Ana ; Abdelrahman, Tamer T. ; Blümel, Johannes ; Terao, Eriko (2019) Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing Journal of Clinical Virology, 119 . pp. 60-67. ISSN 13866532
PDF
2MB |
Official URL: http://doi.org/10.1016/j.jcv.2019.05.006
Related URL: http://dx.doi.org/10.1016/j.jcv.2019.05.006
Abstract
Background: Globally, hepatitis E virus (HEV) is a major cause of acute viral hepatitis. Epidemiology and clinical presentation of hepatitis E vary greatly by location and are affected by the HEV genotype. Nucleic acid amplification technique (NAT)-based assays are important for the detection of acute HEV infection as well for monitoring chronic cases of hepatitis E. Objectives: The aim of the study was to evaluate a panel of samples containing different genotypes of HEV for use in nucleic NAT-based assays. Study design: The panel of samples comprises eleven different members including HEV genotype 1a (2 strains), 1e, 2a, 3b, 3c, 3e, 3f, 4c, 4g as well as a human isolate related to rabbit HEV. Each laboratory assayed the panel members directly against the 1st World Health Organization (WHO) International Standard (IS) for HEV RNA (6329/10) which is based upon a genotype 3 a strain. Results: The samples for evaluation were distributed to 24 laboratories from 14 different countries and assayed on three separate days. Of these, 23 participating laboratories returned a total of 32 sets of data; 17 from quantitative assays and 15 from qualitative assays. The assays used consisted of a mixture of in-house developed and commercially available assays. The results showed that all samples were detected consistently by the majority of participants, although in some cases, some samples were detected less efficiently. Conclusions: Based on the results of the collaborative study the panel (code number 8578/13) was established as the "1st International Reference Panel (IRP) for all HEV genotypes for NAT-based assays" by the WHO Expert Committee on Biological Standardization. This IRP will be important for assay validation and ensuring adequate detection of different genotypes and clinically important sub-genotypes of HEV.
Item Type: | Article |
---|---|
Source: | Copyright of this article belongs to Elsevier B.V. |
Keywords: | Genotype; HEV; Hepatitis E virus; NAAT; NAT; Standardization; World Health Organization. |
ID Code: | 129531 |
Deposited On: | 23 Nov 2022 10:55 |
Last Modified: | 23 Nov 2022 10:55 |
Repository Staff Only: item control page